Ying Liu

Neuroprotective effects of an engineered <i>Escherichia coli</i> Nissle 1917 on Parkinson's disease in mice by delivering <scp>GLP</scp> ‐1 and modulating gut microbiota

Heng Wu, Jing Wei, Xiumiao Zhao et al. · Bioengineering & Translational Medicine · 2022 · 56 citations · Full text

Life Sciences, Biotechnology, Neuroscience +17

A Novel In Situ Gel Formulation of Ranitidine for Oral Sustained Delivery

Haoping Xu, Min Shi, Ying Liu et al. · Biomolecules & Therapeutics · 2014 · 33 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +14

miR-9 targeting RUNX1 improves LPS-induced alveolar hypercoagulation and fibrinolysis inhibition through NF-κB inactivation in ARDS

Chuan Xiao, Qing Li, Jingjing Xiao et al. · International Immunopharmacology · 2023 · 16 citations · Full text

Life Sciences, Molecular Biology, Molecular Medicine +15

6-Gingerol ameliorates alveolar hypercoagulation and fibrinolytic inhibition in LPS-provoked ARDS via RUNX1/NF-κB signaling pathway

Qing Li, Chuan Xiao, Jiarun Gu et al. · International Immunopharmacology · 2024 · 14 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16